Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
about
Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data
P2860
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@en
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@nl
type
label
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@en
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@nl
prefLabel
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@en
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@nl
P2093
P2860
P50
P1433
P1476
Tranexamic acid for hyperacute ...... ed, phase 3 superiority trial.
@en
P2093
Ann Charlotte Laska
Christine Roffe
Daniel Bereczki
David Werring
David Whynes
Ian Roberts
Jason P Appleton
Jegan Thanabalan
Katie Flaherty
Lelia Duley
P2860
P304
P356
10.1016/S0140-6736(18)31033-X
P407
P50
P577
2018-05-16T00:00:00Z